ImmunoPrecise Antibodies Ltd. (HYFT) Stock

NASDAQ: HYFTHealthcare company in the biotechnology industry, based in Austin, TX.

ImmunoPrecise Antibodies stock price chart

HYFT interactive chart →

HYFT stock quote & key statistics

ImmunoPrecise Antibodies earnings per share

Income →
Earnings per share

ImmunoPrecise Antibodies revenue & net income

Income →
RevenueNet income

ImmunoPrecise Antibodies annual financials

Income statement →
Fiscal yearRevenueNet incomeEPS
FY2026$15.3M-$13.7M-$0.26
FY2025$24.5M-$30.2M-$0.67
FY2024$24.5M-$26.1M-$0.35
FY2023$20.7M-$26.6M-$0.81
FY2022$19.4M-$16.7M-$0.67

Fiscal year ending April 30. Source: company filings via EODHD.

About ImmunoPrecise Antibodies Ltd.

MindWalk Holdings Corp. operates as a bio-native AI company. The company discovers and develops biologics through HYFT Technology and LensAI platform, as well as develops AI drug discovery and biologics through ReefIQ technology. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

ImmunoPrecise Antibodies stock FAQ

What is the ImmunoPrecise Antibodies stock ticker symbol?

ImmunoPrecise Antibodies Ltd. trades on the NASDAQ under the ticker symbol HYFT.

What sector and industry is ImmunoPrecise Antibodies in?

ImmunoPrecise Antibodies Ltd. is classified in the Healthcare sector, Biotechnology industry.

How many employees does ImmunoPrecise Antibodies have?

ImmunoPrecise Antibodies Ltd. has about 74 full-time employees.

What were ImmunoPrecise Antibodies's revenue and earnings last fiscal year?

ImmunoPrecise Antibodies reported revenue of $15.3M and net income of -$13.7M in fiscal 2026, with earnings per share of -$0.26. Revenue declined 37.5% from the prior year.

When did ImmunoPrecise Antibodies go public?

ImmunoPrecise Antibodies stock began trading on January 3, 2017.

Biotechnology stocks

All Healthcare stocks →